SMS Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

8.87

8.47

8.47

8.47

8.47

Share application money

15.88

28.58

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

648.33

533.45

486.63

485.30

419.76

Loan funds

Secured loans

310.76

280.18

252.51

260.11

218.69

Unsecured loans

-

-

-

-

-

Total

983.83

850.67

747.61

753.87

646.92

Uses of funds

Fixed assets

Gross block

755.21

627.61

566.20

568.56

556.53

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

222.23

190.35

154.18

130.57

99.17

Net block

532.98

437.26

412.02

437.99

457.36

Capital work-in-progress

34.67

30.27

33.19

11.00

6.74

Investments

45.11

45.10

45.10

45.00

45.00

Net current assets

Current assets, loans & advances

573.35

555.62

423.88

388.98

320.80

Less : current liabilities & provisions

202.28

217.59

166.57

129.10

182.99

Total net current assets

371.07

338.04

257.31

259.88

137.81

Miscellaneous expenses not written

-

-

-

-

-

Total

983.83

850.67

747.61

753.87

646.92

Notes:

Book value of unquoted investments

45.11

45.10

45.10

45.00

45.00

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

21.45

49.91

132.30

138.21

65.97

Number of equity sharesoutstanding (Lacs)

886.52

846.52

846.52

846.52

846.52